secwatch.observer — SEC 8-K summary
======================================

Issuer:     ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
CIK:        0000879407
Form:       8-K
Filed at:   2023-02-08T23:59:59+00:00
Accession:  0001628280-23-002660
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Arrowhead Pharmaceuticals clarifies shares outstanding as of February 1, 2023
-----------------------------------------------------------------------------

- Filed an 8-K on February 7, 2023 to clarify that shares outstanding as of February 1, 2023 were 106,710,568.
- The clarification follows the filing of the quarterly report on Form 10-Q for the first quarter of fiscal 2023 on February 6.
- The company's common stock is listed on Nasdaq under ticker ARWR.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/879407/000162828023002660/0001628280-23-002660-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/879407/000162828023002660/arwr-20230207.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-002660

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer